Mar Del Plata, BUENOS%20AIRES1 Active Studies

Ankylosing Spondylitis Clinical Trials in Mar Del Plata, BUENOS%20AIRES

Find 1 actively recruiting ankylosing spondylitis clinical trials in Mar Del Plata, BUENOS%20AIRES. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
160
Enrolling

Recruiting Ankylosing Spondylitis Studies in Mar Del Plata

About Ankylosing Spondylitis Clinical Trials in Mar Del Plata

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Mar Del Plata, BUENOS%20AIRES. These studies are seeking a combined 160 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Mar Del Plata — FAQ

Are there ankylosing spondylitis clinical trials in Mar Del Plata?

Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Mar Del Plata, BUENOS%20AIRES. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mar Del Plata?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mar Del Plata research site will contact you about next steps.

Are clinical trials in Mar Del Plata free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mar Del Plata studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 1 active trials in Mar Del Plata are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov